Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 15, 2022 - Issue
Submit an article Journal homepage
409
Views
1
CrossRef citations to date
0
Altmetric
Short Report

Facial Seborrheic Dermatitis in HIV-Seropositive Patients: Evaluation of the Efficacy and Safety of a Non-Steroidal Cream Containing Piroctone Olamine, Biosaccharide Gum-2 and Stearyl Glycyrrhetinate – A Case Series

Carolina Cortés-Correa1 Department of Dermatology, Hospital Universitario de la Samaritana, Bogotá, ColombiaView further author information
,
Jaime Piquero-Casals2 Department of Dermatology, Dermik, Multidisciplinary Dermatology Clinic, Barcelona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4481-5602View further author information
ORCID Icon,
Daniela Chaparro-Reyes1 Department of Dermatology, Hospital Universitario de la Samaritana, Bogotá, ColombiaView further author information
,
Aurora Garré Contreras3 Innovation and Development, ISDIN, Barcelona, SpainView further author information
,
Corinne Granger3 Innovation and Development, ISDIN, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0001-5117-448XView further author information
ORCID Icon &
Elkin Peñaranda-Contreras1 Department of Dermatology, Hospital Universitario de la Samaritana, Bogotá, ColombiaView further author information
Pages 483-488 | Published online: 18 Mar 2022

References

  • Mameri ACA, Carneiro S, Mameri LMA, Telles da Cunha JM, Ramos-E-Silva M. History of seborrheic dermatitis: conceptual and clinico-pathologic evolution. Skinmed. 2017;15(3):187–194.
  • Schaub NA, Drewe J, Sponagel L, et al. Is there a relationship between risk groups or initial CD4 T cell counts and prevalence of seborrheic dermatitis in HIV-infected patients? Dermatology. 1999;198:126–129. doi:10.1159/000018087
  • Forrestel AK, Kovarik CL, Mosam A, Gupta D, Maurer TA, Micheletti RG. Diffuse HIV-associated seborrheic dermatitis - a case series. Int J STD AIDS. 2016;27(14):1342–1345. doi:10.1177/0956462416641816
  • Schechtman RC, Midgley G, Hay RJ. HIV disease and Malassezia yeasts: a quantitative study of patients presenting with seborrheic dermatitis. Br J Dermatol. 1995;133:694–698. doi:10.1111/j.1365-2133.1995.tb02740.x
  • Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29(5):481–489. doi:10.1111/exd.14091
  • Chen P, He G, Qian J, Zhan Y, Xiao R. Potential role of the skin microbiota in inflammatory skin diseases. J Cosmet Dermatol. 2021;20(2):400–409. doi:10.1111/jocd.13538
  • Gupta A, Versteeg S. Topical treatment of facial seborrheic dermatitis: a systematic review. Am J Clin Dermatol. 2017;18(2):193–213. doi:10.1007/s40257-016-0232-2
  • Purnamawati S, Indrastuti N, Danarti R, Saefudin T. The role of moisturizers in addressing various kinds of dermatitis: a review. Clin Med Res. 2017;15(3–4):75–87. doi:10.3121/cmr.2017.1363
  • Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014;28(1):16–26. doi:10.1111/jdv.12197
  • Dall’Oglio F, Lacarruba F, Luca M, Boscaglia S, Granger C, Micali G. Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis. Clin Cosmet Investig Dermatol. 2019;12:103–108. doi:10.2147/CCID.S186621
  • Balato A, Caiazzo G, Di Caprio R, Scala E, Fabbrocini G, Granger C. Exploring anti-fungal, anti-microbial and anti-inflammatory properties of a topical non-steroidal barrier cream in face and chest seborrheic dermatitis. Dermatol Ther. 2020;10(1):87–98. doi:10.1007/s13555-019-00339-w
  • Piquero-Casals J, La Rotta-higuera E, Francisco Mir-Bonafé J, Rozas-Muñoz E, Granger C. Non-steroidal topical therapy for facial seborrheic dermatitis. J Drugs Dermatol. 2020;19(6):658–660. doi:10.36849/JDD.2020.5121
  • Granger C, Goni F, Martinez G, Garre A. Ex-vivo determination of antifungal activity of a new prescription non-steroidal facial cream against Malassezia furfur in human skin explants. Skin J Cutan Med. 2017;1:137. doi:10.25251/skin.1.supp.136
  • Oyama K, Kawada-Matsuo M, Oogai Y, Hayashi T, Nakamura N, Komatsuzawa H. Antibacterial effects of glycyrrhetinic acid and its derivatives on Staphylococcus aureus. PLoS One. 2016;11(11):e0165831. doi:10.1371/journal.pone.0165831
  • Krzyściak P, Bakuła Z, Gniadek A, et al. Prevalence of Malassezia species on the skin of HIV-seropositive patients. Sci Rep. 2020;10(1):17779. doi:10.1038/s41598-020-74133-6
  • Moreno-Coutiño G, Sánchez-Cárdenas CD, Bello-Hernández Y, Fernández-Martínez R, Arroyo-Escalante S, Arenas R. Isolation of Malassezia spp. in HIV-positive patients with and without seborrheic dermatitis. An Bras Dermatol. 2019;94(5):527–531. doi:10.1016/j.abd.2019.09.012
  • de Moraes AP, de Arruda EA, Vitoriano MA, et al. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV. J Eur Acad Dermatol Venereol. 2007;21(5):596–601. doi:10.1111/j.1468-3083.2006.01923.x
  • Edelman EJ, Rentsch CT, Justice AC. Polypharmacy in HIV: recent insights and future directions. Curr Opin HIV AIDS. 2020;15(2):126–133. doi:10.1097/COH.0000000000000608

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.